Drug Trial Radar · NCT00963469
Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)
Last checked: Nov 19, 2026Latest source record: Feb 3, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,079
Actual
Start
Aug 2001
Primary completion
Nov 2001
Study completion Nov 2001
Sponsor
- Lead sponsor
- Organon and CoIndustry
- Sponsor type
- Industry
- First posted
- Aug 21, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 15 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to evaluate the treatment effect of montelukast 10 mg taken in the morning, versus placebo, in patients with seasonal allergic rhinitis. Loratadine is included in the study as an active control.
Conditions
- Seasonal Allergic Rhinitis
Interventions
montelukast sodiumDrug
montelukast 10 mg tablet orally once daily in the morning for 4 weeks
Comparator: loratadineDrug
loratadine 10 mg tablet orally once daily in the morning for 4 weeks
Comparator: placeboDrug
placebo tablet orally once daily in the morning for 4 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Baseline in Daytime Nasal Symptoms Score Over First 2 Weeks of Treatment PeriodTime frame: Baseline and first 2 Weeks of treatment period (from randomization through the end of Week 2)
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.